Cargando…
Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
OBJECTIVE: To determine treatment patterns and costs over a two-year period among new initiators of topical prostaglandin analogs in a managed care population by retrospective cohort analysis of an insurance claims database. METHODS: Patients who initiated therapy with a prostaglandin analog between...
Autores principales: | Schmier, Jordana K, Lau, Edmund C, Covert, David W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952617/ https://www.ncbi.nlm.nih.gov/pubmed/20957061 http://dx.doi.org/10.2147/OPTH.S13884 |
Ejemplares similares
-
First-year treatment costs among new initiators of topical prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2009) -
First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results
por: Schmier, Jordana K, et al.
Publicado: (2010) -
Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2014) -
Characteristics of respondents with glaucoma and dry eye in a national panel survey
por: Schmier, Jordana K, et al.
Publicado: (2009) -
An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010–2014
por: Schmier, Jordana K, et al.
Publicado: (2016)